Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PHCC Priority Healthcare -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (13)	12/28/2000 5:26:27 PM
From: blebovits	Respond to of 103

PHCC : Today's High 40 PRIORITY HEALTHCARE 'B' (NASDAQ) 5:24 PM ET Last Trade 39 1/8 Open 37 3/8 EPS Growth Rate 51.58% Change +1 3/4 Previous Close 37 3/8 EPS (TTM) 0.66 % Change +4.7% Today's High 40 P/E 56.97 Last Trade 4:00 PM Today's Low 36 5/8 Market Cap 1.78 Bil Bid 38 1/2 52 Wk High 40 1/2 Shares Outstanding 45.40 Mil Ask 39 3/8 52 Wk Low 11.84 Dividend 0.00 Volume 581,300 Avg Daily Vol 676,000 Yield 0.00 Company News

To: StockDung who wrote (13)	12/31/2000 9:09:57 AM
From: afrayem onigwecher	Read Replies (1) \| Respond to of 103

Boy, it has been great .... making a lot of money trading this stock on up moves. Yup, the glass is half full

To: StockDung who wrote (13)	1/23/2001 6:16:05 PM
From: blebovits	Read Replies (1) \| Respond to of 103

Priority Healthcare Closes Acquisition Of Freedom Drug LAKE MARY, Fla., Jan. 22 /PRNewswire/ -- Priority Healthcare Corporation (Nasdaq: PHCC - news) announced today they have closed the previously announced acquisition of Freedom Drug located in Lynnfield, Massachusetts. Freedom Drug is the nation's leading infertility specialty pharmacy providing total patient management services for infertility patients and their physicians. Priority Healthcare Corporation is a provider of patient-specific, self- injectable biopharmaceuticals and disease treatment programs to individuals with chronic diseases and a national distributor of specialty pharmaceuticals and related medical supplies to the alternate healthcare market. Certain information in this press release contains forward-looking statements as defined in Section 27A of the Securities Act and 21E of the Exchange Act. Certain factors, including those described in our filings with the SEC, could cause actual results to differ materially from those in the forward-looking statements. SOURCE: Priority Healthcare Corporation